Please assess the completion status of the following clinical trial:

Trial Title: Sleep Apnea and Fetal Growth Restriction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 and ≤ 50~* Fetal growth restriction (defined as fetal weight \<10th percentile based on at least one routine 2nd trimester ultrasound without a subsequent increase to \>15th percentile on any ultrasounds prior to enrollment)~* Lower limit of gestational age at enrollment 22+0 weeks.~* Upper limit of gestational age at enrollment: adequate time to complete Stages 1 and 2 and if appropriate to be randomized and receive intervention by no later than 32+0 weeks.~* The absence of 2 minor or 1 major markers of aneuploidy.~Exclusion Criteria:~* Other known cause of fetal growth restriction (including congenital anomalies, intrauterine infection, or multiple gestation)~* Reversed end-diastolic flow in the umbilical artery~* Preexisting diagnosis of OSA being treated with aPAP~* Chronic pulmonary disease (cystic fibrosis, moderate persistent asthma)~* Hemoglobinopathies (sickle cell anemia, thalassemia)~* Maternal craniofacial anomalies~* Premature rupture of membranes

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- aPAP (Type: EXPERIMENTAL): Nightly use of aPAP when sleeping through the date of delivery
- No aPAP (Type: NO_INTERVENTION): No use of aPAP (standard of care)

Based on this trial design, predict the completion outcome and termination type (if applicable).